Structure Activity Relationships SARs

The structure-activity relationship (SAR) is a means by which the effect of a drug or toxic chemical on an animal, plant or the environment can be related to its 

Computational models are used in human health risk assessment to predict the biological activity of potentially health-threatening agents. Structure-activity relationships that relate chemical structure to biological activity are examples of such models. Once a model is developed, it is used to predict the activity of new chemicals. The success or failure of a SAR model lies in its ability to predict correctly the true activity of a chemical. 

Hazard assessment of environmental pollutants requires the input of many physicochemical, biomedical and toxicological properties of large numbers of chemicals in the various decision-making steps. Unfortunately, most of the candidate chemicals have very little or no laboratory data, a prerequisite to their proper evaluation. Modem combinatorial chemistry is quickly producing large libraries of real or virtual chemicals for which almost no property is known except their molecular structure. 

One solution to this quagmire has been the use of calculated properties estimated from the molecular structure of chemicals instead of their experimental data. Molecular descriptors calculated using different variations of the chemical stmcture lead to the development of quantitative structure-property/activity relationship (QSPR/QSAR) models. 

In general, SARs predict the toxicity of organic compounds based on their physical and chemical properties, particularly in the field of carcinogenesis. Toxicants move from the environment into the organisms, to exert their toxic action within the cells. Both processes depend on the elemental composition and stmcture of the chemical. 

Fundamentals of Medicinal Chemistry, Edited by Gareth Thomas 

---

The structure activity relationships ( SAR) of newly synthesized analogues of nucleosides, xanthine heterocycles, and nonxanthine heterocycles have been explored at the ARs. Potent and selective AR antagonists have been prepared for all four subtypes [3, 4], and selective agonists are known for three subtypes [1]. Thus, numerous pharmacological tools are available for in vitro and in vivo use (Table 2). Potent and selective A2b AR agonists are yet to be repotted, although several research groups have identified lead compounds. 

Most relevant for the affinity for A9-THC and analogs to CB-receptors are the phenolic hydroxyl group at C-1, the kind of substitution at C-9, and the properties of the side chain at C-3. Relating to the structure-activity relationships (SAR) between cannabinoids and the CB-receptors, many different modified strucfures of fhis subsfance group were developed and fesfed. The most important variations include variations of the side chain at the olivetolic moiety of the molecules and different substitutions at positions C-11 and C-9. One of the most popular analogous compounds of A9-THC is HU-210 or (-)-trans-ll-OH-A8-THC-DMH, a cannabinoid with a F,l-dimethylheptyl side... 

To establish the structure-activity relationships (SARs) of a set of molecules, a knowledge of the 3D structure is of great importance [2]. Thevand et al. recently (2004) reported the 3D structural analysis of tetrandrine using NMR and molecular modeling (the structure is shown in Fig. 1) [2]. They employed... 

The in vivo antihistaminic activity results indicate that all test compounds protected the animals from histamine-induced bronchospasm significantly. Structural activity relationship (SAR) studies indicated that different alkyl substituents on the first position of the triazoloquinazohne ring exerted varied biological activity. 

One of the sources of the fuzziness surrounding these concepts may well be the implicit assumption in structure-activity relationship (SAR) studies that molecular structure contains (i.e. encodes) the information on the biological activity of a given compound. Such an assumption cannot be incorrect, since this would imply the fallacy of SAR studies. However, the assumption becomes misleading if not properly qualified to the effect that the molecular structure of a given compound contains only part of the information on its bioactivity. Indeed, what the structure of a compound encodes is information about the molecular features accounting... 

This article summarises the general characteristics of a novel antibacterial target, peptide deformylase (PDF) and reviews the design, structure-activity relationships (SAR) and properties of known PDF inhibitors, including pre-clinical and clinical data for the most advanced members of this class. 

The first non-peptide oxytocin antagonists, based on a spiropiperidine template, were described by Merck in 1992 [68-70]. The binding affinity data for key compounds from this series are summarised in Table 7.2. The initial screening hit, L-342,643, (23), had modest (4/iM) affinity for rat uterine oxytocin receptors and very little vasopressin selectivity [71]. A structure activity relationship (SAR) study was carried out around this template, focussing on the toluenesulphonamide group. This work led to the identification of bulky lipophilic substitution as key to improved oxytocin potency, while the introduction of a carboxylic acid group led to improved... 

Another characteristic of PCP which has been studied with great interest over the last 5 years, is the ability of PCP to produce a discriminative stimulus in monkeys, rats, and pigeons. As discussed elsewhere in this volume, by Browne, the discriminative stimulus properties of PCP are shared not only by other members of the arylcycloalkylamine class, but by psychotomimetic benzo-morphans and substituted dioxolanes. The structure-activity relationships (SAR) within and between these classes are virtually identical to those found when studying the displacement of 3H-PCP from its binding site in rat brain membranes. This correlation... 

Perhaps the advantage of the medicinal chemistry route lies in the flexibility of introducing different alkyl groups on the primary amine through reductive amination on 2-aminoethyl indole 10 and hence allows access to various N, N-dialkyl tryptamine derivatives for structure-activity relationship (SAR) studies. 

Successful HTS campaigns often result in multiple lead pharmacophores that must be individually optimized through structure-activity relationship (SAR) studies. 

Predictions based on structure-activity relationships (SARs), including qualitative and quantitative mathematical models, and the use of read-across data from related chemicals. 

A rational approach to problems such as drug targeting to regions protected by P-gp, inhibition or even prevention of multidrug resistance in different organisms, and prediction of drug-drug interactions due to P-gp should become possible with reliable structure-activity relationship (SAR) studies. 

---